Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Prepares Prototypes Of Consumer Medical Information Options

This article was originally published in The Pink Sheet Daily

Executive Summary

Workshop in September will gather input on how to ensure patients understand both risks and benefits.

You may also be interested in...

FDA Poised To Overhaul Distribution Of Consumer Medical Information

FDA appears poised to begin an overhaul of the dissemination of consumer drug information

FDA Risk Communication Advisory Cmte. Will Assess Pharmacy Leaflets’ Utility

FDA's Risk Communication Advisory Committee will meet Feb. 26-27 to discuss how to improve the usability of consumer medical information leaflets distributed by pharmacies with prescription drugs

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts